Figure 3.

Endometrial apoA-I expression and plasma levels in fertile and infertile patients during the mid-luteal phase of the cycle. (A) Nineteen of the 25 endometrial samples used for SELDI-TOF-MS were resolved on SDS–PAGE and immunoblotted for apoA-I. Control samples from fertile patients are indicated as C1-10, whereas biopsies from patients with RIF are denoted RIF1-9. β-Actin served as loading control. (B) Circulating apoA-I and HDL levels at the time of biopsy were determined in serum samples of fertile women (controls, n = 15) and patients with RIF (n = 10); P > 0.05.